MAM
ALXO icon

Martingale Asset Management’s ALX Oncology ALXO Stock Holding History

Martingale Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,195
Closed -$404K – 785
2024
Q1 		$404K Sell
36,195
-5,914
-14% -$83.1K 0.01% 657
2023
Q4 		$627K Sell
42,109
-2,500
-6% -$23.7K 0.01% 556
2023
Q3 		$214K Hold
44,609
– – ﹤0.01% 740
2023
Q2 		$335K Hold
44,609
– – 0.01% 680
2023
Q1 		$202K Hold
44,609
– – ﹤0.01% 780
2022
Q4 		$503K Sell
44,609
-3
-0% -$34 0.01% 613
2022
Q3 		$427K Buy
44,612
+2,679
+6% +$31.2K 0.01% 647
2022
Q2 		$340K Buy
+41,933
New +$457K 0.01% 717

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Martingale Asset Management's ALXO Position: Q2 2024 in Review

Martingale Asset Management sold out of ALX Oncology (ALXO) in Q2 2024, closing a stake of 36,195 shares — an estimated $404K sold.

Martingale Asset Management first reported a position in ALXO in Q2 2022 and held it in 8 quarters. The position peaked at $627K in Q4 2023. 111 funds tracked by Wall St. Rank hold ALXO as of Q2 2024.

  • Martingale Asset Management reported no remaining ALX Oncology position as of Q2 2024 after selling out during the quarter.
  • Martingale Asset Management sold 36,195 ALX Oncology shares in Q2 2024, an estimated $404K.
  • Martingale Asset Management first reported a position in ALX Oncology in Q2 2022 and held it in 8 quarters.
  • Martingale Asset Management's ALX Oncology position peaked at $627K in Q4 2023.
  • 111 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2024.

Based on Martingale Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.